Radiotherapy and nuclear medicine basics: radiotherapy for high-risk prostate cancer: practice question

A Radiology question in the style of the NEET PG paper. Answer it first, then read why the right option is right and why each of the others is wrong.

Try it

Radiology · Radiotherapy and nuclear medicine basics: radiotherapy for high-risk prostate cancer

Sample item

A man with locally advanced prostate cancer is treated with external beam radiotherapy. Which addition improves survival?

Original practice item, not a recalled exam question. Nothing here is recorded.

The answer and the reasoning

B. Androgen deprivation therapy

In locally advanced or high-risk disease, adding androgen deprivation to radiotherapy improves local control and survival. Tamoxifen, imatinib and radioiodine do not act on prostate cancer.

Option by option

  • A. Radioiodine

    Radioiodine treats thyroid disease.

  • B. Androgen deprivation therapy (correct)

    Correct. Androgen deprivation with radiotherapy improves survival in high-risk disease.

  • C. Imatinib

    Imatinib targets tyrosine kinases in CML and GIST.

  • D. Tamoxifen

    Tamoxifen is an anti-oestrogen used in breast cancer.

Source note: Original NextPrep sample item — pending expert review. This item is original practice material awaiting independent expert review, so confirm important facts in a standard textbook.

More Radiology questions

Questions about this Radiology question

What is the answer to this Radiology question?

The best answer is B, Androgen deprivation therapy. In locally advanced or high-risk disease, adding androgen deprivation to radiotherapy improves local control and survival.

Why is "Radioiodine" not the answer?

Radioiodine treats thyroid disease.

Why is "Imatinib" not the answer?

Imatinib targets tyrosine kinases in CML and GIST.

Why is "Tamoxifen" not the answer?

Tamoxifen is an anti-oestrogen used in breast cancer.

What concept does this question test?

It tests Radiotherapy and nuclear medicine basics: radiotherapy for high-risk prostate cancer in Radiology. Tamoxifen, imatinib and radioiodine do not act on prostate cancer.

How hard is this question?

We tag it as an application question: it asks you to use a fact on a patient or a finding. The tag is our own editorial judgement, not an official difficulty rating, so read the reason for every option, not only the answer.

How should I study Radiotherapy and nuclear medicine basics: radiotherapy for high-risk prostate cancer?

Learn signs with the image, and the disease they point to. Then use the flashcards and the other Radiology questions on this site to test what stuck.

Is this a real NEET PG question?

No. It is an original practice item (editorial status: sample, version 1). NextPrep does not publish recalled or leaked questions, and independent faculty review of this item has not been completed yet, so confirm important facts in a standard textbook.